Learn About IWILFIN
IWILFIN is a prescription medicine used to reduce the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who have had at least a partial response to certain prior therapies.
All images used on iwilfin.com are actor portrays and not real patients.
"I Will Do All I Can To Protect My Child From Relapse"
The first and only FDA-approved oral maintenance therapy shown to cut the risk of high-risk neuroblastoma (HRNB) relapse in half.
Learn About IWILFIN
IWILFIN is a prescription medicine used to reduce the risk of relapse in adults and children with high-risk neuroblastoma (HRNB) who have had at least a partial response to certain prior therapies.
The Inspiration Behind IWILFIN
Patients and caregivers are at the heart of every treatment journey. Watch this video to learn more about the inspiration behind IWILFIN and the resilience of those navigating care.
To improve your experience, we (and our partners) store and/or access information on your browser (cookie or equivalent) with your consent for this website. We may use these cookies to: measure the audience of the advertising on our website, display personalized ads based on your navigation, send you advertising based on your location. Learn more in our privacy policy.
We use this data to understand how visitors use our website and improve their experience.
We and our partners use this information to show you personalized and relevant advertisements.